Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results